Engineered galactose oxidase variant enzymes
US12012618B2 · kind B2 · utility
0Cited by
130References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 2022 |
| Grant date | Jun 18, 2024 |
| Priority date | — |
| Expiry date | Sep 9, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y101/03009
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides engineered galactose oxidase (GOase) enzymes, polypeptides having GOase activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing GOase enzymes are also provided. The present invention further provides compositions comprising the GOase enzymes and methods of using the engineered GOase enzymes. The present invention finds particular use in the production of pharmaceutical and other compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.